Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,434 | 38,680 | 29,567 | 23,995 | 15,673 |
| Receivables | 51,469 | 47,300 | 49,323 | 50,676 | 44,440 |
| Inventories | 34,460 | 35,297 | 32,763 | 28,216 | 33,156 |
| Income taxes - deferred | 2,450 | 2,709 | 2,748 | 3,200 | 3,233 |
| TOTAL | $138,381 | $132,217 | $124,580 | $113,424 | $107,387 |
| Non-Current Assets | |||||
| PPE Net | 128,369 | 129,120 | 132,875 | 135,519 | 141,495 |
| Investments And Advances | 956 | 956 | 956 | 0 | 956 |
| Intangibles | 3,057 | 3,131 | 3,075 | 3,065 | 3,119 |
| Other Non-Current Assets | 6,643 | 7,444 | 8,511 | 10,854 | 11,510 |
| TOTAL | $139,025 | $140,651 | $145,417 | $149,438 | $157,080 |
| Total Assets | $277,406 | $272,868 | $269,997 | $262,862 | $264,467 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,024 | 1,024 | 954 | 776 | 597 |
| Accounts payable and accrued liabilities | 28,887 | 28,900 | 22,102 | 18,194 | 26,001 |
| Accrued Expenses | 260 | 284 | 543 | 5,786 | 284 |
| Other current liabilities | 1,693 | 2,034 | 2,376 | 2,717 | 3,058 |
| TOTAL | $42,596 | $42,080 | $36,557 | $35,986 | $38,149 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,384 | 6,563 | 7,048 | 7,227 | 7,407 |
| Deferred Revenues | 9,668 | 9,838 | 8,245 | 7,365 | 7,205 |
| Other Non-Current Liabilities | 10,118 | 10,668 | 9,535 | 9,898 | 10,248 |
| TOTAL | $19,147 | $20,209 | $19,864 | $20,735 | $21,757 |
| Total Liabilities | $61,743 | $62,289 | $56,421 | $56,721 | $59,906 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,617 | 31,582 | 31,418 | 31,337 | 30,924 |
| Common Shares | 370 | 369 | 368 | 363 | 363 |
| Retained earnings | 83,365 | 79,435 | 81,682 | 75,177 | 73,261 |
| Other shareholders' equity | -12,851 | -12,672 | -10,741 | -10,183 | -9,850 |
| TOTAL | $215,663 | $210,579 | $213,576 | $206,141 | $204,561 |
| Total Liabilities And Equity | $277,406 | $272,868 | $269,997 | $262,862 | $264,467 |